ovcar-3 cell lines Search Results


93
CLS Cell Lines Service GmbH ovcar3 cells
Caspase8 inhibition compounds cytotoxicity in ovarian cancer cells treated with IKK β inhibitor. Caspase8 shRNA toxicity in a sensitization library screen is shown as ( a ) the log2 ratio of untreated versus IKK β -inhibited, or ( b ) log 10 P -value, after 10 days. Caspase8 shRNAs are highlighted in black. ( c ) Cell viability of <t>Ovcar3,</t> Caov3 and PEO1 cells transduced with control shRNA or either of two different Caspase8 shRNAs was measured by XTT after 7 days of exposure to increasing concentrations of IKK β inhibitor. Data are shown as fold control shRNA, in the absence of IKK β inhibitor (DMSO), ±S.E.M., n =8. Asterisks indicate significant differences ( P <0.01) at the concentration range used in subsequent studies. ( d ) Ovcar3 cells were transduced with Caspase8 shRNAs #1, #2, #3 or #4 or control shRNA and exposed to 2.5 μ M IKK β inhibitor or vehicle for 7 days. Viability was measured by XTT and is shown as fold control shRNA and drug control (DMSO). Error bars represent S.E.M., n =8; *P <0.001. ( e ) Ovcar3 cells expressing control or Caspase8 shRNA #2 were treated with 2.5 μ M IKK β inhibitor for 7 days. ( f ) Three ovarian cell lines sensitive to IKK β inhibition (Ovcar3, Caov3 and Igrov1) and one insensitive cell line (Ovcar8) were stained by IHC with NF- κ B-p65 and Caspase8 antibodies and the presence of nuclear protein analyzed. IHC scores for relative amounts of nuclear NF- κ B-p65 and Caspase8 were measured in four to six uniform fields per sample and averaged. Numbers are average scores ±S.E.M.
Ovcar3 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/OVCAR-3+Cells/pmc05198842-190-0-22
Average 93 stars, based on 1 article reviews
ovcar3 cells - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
AMS Biotechnology ovcar
Caspase8 inhibition compounds cytotoxicity in ovarian cancer cells treated with IKK β inhibitor. Caspase8 shRNA toxicity in a sensitization library screen is shown as ( a ) the log2 ratio of untreated versus IKK β -inhibited, or ( b ) log 10 P -value, after 10 days. Caspase8 shRNAs are highlighted in black. ( c ) Cell viability of <t>Ovcar3,</t> Caov3 and PEO1 cells transduced with control shRNA or either of two different Caspase8 shRNAs was measured by XTT after 7 days of exposure to increasing concentrations of IKK β inhibitor. Data are shown as fold control shRNA, in the absence of IKK β inhibitor (DMSO), ±S.E.M., n =8. Asterisks indicate significant differences ( P <0.01) at the concentration range used in subsequent studies. ( d ) Ovcar3 cells were transduced with Caspase8 shRNAs #1, #2, #3 or #4 or control shRNA and exposed to 2.5 μ M IKK β inhibitor or vehicle for 7 days. Viability was measured by XTT and is shown as fold control shRNA and drug control (DMSO). Error bars represent S.E.M., n =8; *P <0.001. ( e ) Ovcar3 cells expressing control or Caspase8 shRNA #2 were treated with 2.5 μ M IKK β inhibitor for 7 days. ( f ) Three ovarian cell lines sensitive to IKK β inhibition (Ovcar3, Caov3 and Igrov1) and one insensitive cell line (Ovcar8) were stained by IHC with NF- κ B-p65 and Caspase8 antibodies and the presence of nuclear protein analyzed. IHC scores for relative amounts of nuclear NF- κ B-p65 and Caspase8 were measured in four to six uniform fields per sample and averaged. Numbers are average scores ±S.E.M.
Ovcar, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/NIH%3AOVCAR-3+%5BOVCAR3%5D+Cell+Line/10__1016_slash_j__tet__2020__131754-274-5-29
Average 96 stars, based on 1 article reviews
ovcar - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Nanjing KeyGen Biotech Co Ltd ovarian cancer cell line ovcar3
Caspase8 inhibition compounds cytotoxicity in ovarian cancer cells treated with IKK β inhibitor. Caspase8 shRNA toxicity in a sensitization library screen is shown as ( a ) the log2 ratio of untreated versus IKK β -inhibited, or ( b ) log 10 P -value, after 10 days. Caspase8 shRNAs are highlighted in black. ( c ) Cell viability of <t>Ovcar3,</t> Caov3 and PEO1 cells transduced with control shRNA or either of two different Caspase8 shRNAs was measured by XTT after 7 days of exposure to increasing concentrations of IKK β inhibitor. Data are shown as fold control shRNA, in the absence of IKK β inhibitor (DMSO), ±S.E.M., n =8. Asterisks indicate significant differences ( P <0.01) at the concentration range used in subsequent studies. ( d ) Ovcar3 cells were transduced with Caspase8 shRNAs #1, #2, #3 or #4 or control shRNA and exposed to 2.5 μ M IKK β inhibitor or vehicle for 7 days. Viability was measured by XTT and is shown as fold control shRNA and drug control (DMSO). Error bars represent S.E.M., n =8; *P <0.001. ( e ) Ovcar3 cells expressing control or Caspase8 shRNA #2 were treated with 2.5 μ M IKK β inhibitor for 7 days. ( f ) Three ovarian cell lines sensitive to IKK β inhibition (Ovcar3, Caov3 and Igrov1) and one insensitive cell line (Ovcar8) were stained by IHC with NF- κ B-p65 and Caspase8 antibodies and the presence of nuclear protein analyzed. IHC scores for relative amounts of nuclear NF- κ B-p65 and Caspase8 were measured in four to six uniform fields per sample and averaged. Numbers are average scores ±S.E.M.
Ovarian Cancer Cell Line Ovcar3, supplied by Nanjing KeyGen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/cell+line+ovcar3/pm32783402-37-0-18
Average 90 stars, based on 1 article reviews
ovarian cancer cell line ovcar3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank ovcar3
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovcar3, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovcar+3/pmc02720250-71-5-13
Average 90 stars, based on 1 article reviews
ovcar3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Inserm Transfert ovary carcinoma cell lines (ovcar-3 and o114)
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovary Carcinoma Cell Lines (Ovcar 3 And O114), supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovary+carcinoma+cell+lines++ovcar+3+and+o114+/pmc02571940-169-0-28
Average 90 stars, based on 1 article reviews
ovary carcinoma cell lines (ovcar-3 and o114) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cold Spring Harbor Laboratory Meetings ovcar-3 cell line
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovcar 3 Cell Line, supplied by Cold Spring Harbor Laboratory Meetings, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovcar+3+cell+line/pmc09098222-235-2-12
Average 90 stars, based on 1 article reviews
ovcar-3 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human high-grade serous ovarian carcinoma cell line ov-90
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Human High Grade Serous Ovarian Carcinoma Cell Line Ov 90, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/human+ovarian+cancer+cell+lines+ovcar+3/10__2147_slash_ott__s167106-64-41-52
Average 90 stars, based on 1 article reviews
human high-grade serous ovarian carcinoma cell line ov-90 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pasteur Institute ovarian cancer cell line ovcar-3
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovarian Cancer Cell Line Ovcar 3, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovarian+cancer+cell+line+ovcar+3/pmc07714018-74-1-9
Average 90 stars, based on 1 article reviews
ovarian cancer cell line ovcar-3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell human ovarian cancer ovcar-3 cell line
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Human Ovarian Cancer Ovcar 3 Cell Line, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/human+ovarian+cancer+ovcar+3+cell+line/pmc04637568-93-0-8
Average 90 stars, based on 1 article reviews
human ovarian cancer ovcar-3 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Crown Bioscience ovcar3 human cell line-derived ovarian cancer model
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovcar3 Human Cell Line Derived Ovarian Cancer Model, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovcar3+human+cell+line+derived+ovarian+cancer+model/pmc06324689-177-22-37
Average 90 stars, based on 1 article reviews
ovcar3 human cell line-derived ovarian cancer model - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Inserm Transfert ovary carcinoma cell lines ovcar-3
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovary Carcinoma Cell Lines Ovcar 3, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovary+carcinoma+cell+lines+ovcar+3/us08604166-297-0-17
Average 90 stars, based on 1 article reviews
ovary carcinoma cell lines ovcar-3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
LGC Promochem ovarian adenocarcinoma cell line nih:ovcar-3 (htb161)
Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, <t>OVCAR3,</t> SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.
Ovarian Adenocarcinoma Cell Line Nih:Ovcar 3 (Htb161), supplied by LGC Promochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovcar-3+cell+lines/ovarian+adenocarcinoma+cell+line+nih+ovcar+3++htb161+/pm18719363-125-1-10
Average 90 stars, based on 1 article reviews
ovarian adenocarcinoma cell line nih:ovcar-3 (htb161) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Caspase8 inhibition compounds cytotoxicity in ovarian cancer cells treated with IKK β inhibitor. Caspase8 shRNA toxicity in a sensitization library screen is shown as ( a ) the log2 ratio of untreated versus IKK β -inhibited, or ( b ) log 10 P -value, after 10 days. Caspase8 shRNAs are highlighted in black. ( c ) Cell viability of Ovcar3, Caov3 and PEO1 cells transduced with control shRNA or either of two different Caspase8 shRNAs was measured by XTT after 7 days of exposure to increasing concentrations of IKK β inhibitor. Data are shown as fold control shRNA, in the absence of IKK β inhibitor (DMSO), ±S.E.M., n =8. Asterisks indicate significant differences ( P <0.01) at the concentration range used in subsequent studies. ( d ) Ovcar3 cells were transduced with Caspase8 shRNAs #1, #2, #3 or #4 or control shRNA and exposed to 2.5 μ M IKK β inhibitor or vehicle for 7 days. Viability was measured by XTT and is shown as fold control shRNA and drug control (DMSO). Error bars represent S.E.M., n =8; *P <0.001. ( e ) Ovcar3 cells expressing control or Caspase8 shRNA #2 were treated with 2.5 μ M IKK β inhibitor for 7 days. ( f ) Three ovarian cell lines sensitive to IKK β inhibition (Ovcar3, Caov3 and Igrov1) and one insensitive cell line (Ovcar8) were stained by IHC with NF- κ B-p65 and Caspase8 antibodies and the presence of nuclear protein analyzed. IHC scores for relative amounts of nuclear NF- κ B-p65 and Caspase8 were measured in four to six uniform fields per sample and averaged. Numbers are average scores ±S.E.M.

Journal: Cell Death Discovery

Article Title: A dual role for Caspase8 and NF- κ B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival

doi: 10.1038/cddiscovery.2015.53

Figure Lengend Snippet: Caspase8 inhibition compounds cytotoxicity in ovarian cancer cells treated with IKK β inhibitor. Caspase8 shRNA toxicity in a sensitization library screen is shown as ( a ) the log2 ratio of untreated versus IKK β -inhibited, or ( b ) log 10 P -value, after 10 days. Caspase8 shRNAs are highlighted in black. ( c ) Cell viability of Ovcar3, Caov3 and PEO1 cells transduced with control shRNA or either of two different Caspase8 shRNAs was measured by XTT after 7 days of exposure to increasing concentrations of IKK β inhibitor. Data are shown as fold control shRNA, in the absence of IKK β inhibitor (DMSO), ±S.E.M., n =8. Asterisks indicate significant differences ( P <0.01) at the concentration range used in subsequent studies. ( d ) Ovcar3 cells were transduced with Caspase8 shRNAs #1, #2, #3 or #4 or control shRNA and exposed to 2.5 μ M IKK β inhibitor or vehicle for 7 days. Viability was measured by XTT and is shown as fold control shRNA and drug control (DMSO). Error bars represent S.E.M., n =8; *P <0.001. ( e ) Ovcar3 cells expressing control or Caspase8 shRNA #2 were treated with 2.5 μ M IKK β inhibitor for 7 days. ( f ) Three ovarian cell lines sensitive to IKK β inhibition (Ovcar3, Caov3 and Igrov1) and one insensitive cell line (Ovcar8) were stained by IHC with NF- κ B-p65 and Caspase8 antibodies and the presence of nuclear protein analyzed. IHC scores for relative amounts of nuclear NF- κ B-p65 and Caspase8 were measured in four to six uniform fields per sample and averaged. Numbers are average scores ±S.E.M.

Article Snippet: Ovcar3 cells were transduced with a lentiviral vector containing an NF- κ B transcriptional regulatory element, using the Cignal Lenti Reporter System (CLS-013L, Qiagen, Valencia, CA, USA).

Techniques: Inhibition, shRNA, Transduction, Control, Concentration Assay, Expressing, Staining

IKK β inhibition downregulates NF- κ B signaling and caspase activation after TNF α stimulation. ( a ) Ovcar3 cells expressing control or Caspase8 shRNA were transduced with NF- κ B luciferase reporter. NF- κ B signaling in was measured after 18 h treatment with TNF α (10 ng/ml) and/or IKK β inhibitor (2.5 μ M). Data are arbitrary luciferase units normalized to XTT and are represented as mean±S.E.M.; * P <0.05 based on t -test. ( b ) mRNA expression of Caspase8 and NF- κ B target genes cFLIP, CLDN1, CXCL1, CXCL2 and IL-8 was measured by quantitative RT-PCR in Ovcar3 cells, expressing either control or Caspase8 shRNA. Expression was normalized to that of GAPDH, and expressed as mean±S.E.M. of triplicate experiments. * P <0.05 based on t -test.

Journal: Cell Death Discovery

Article Title: A dual role for Caspase8 and NF- κ B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival

doi: 10.1038/cddiscovery.2015.53

Figure Lengend Snippet: IKK β inhibition downregulates NF- κ B signaling and caspase activation after TNF α stimulation. ( a ) Ovcar3 cells expressing control or Caspase8 shRNA were transduced with NF- κ B luciferase reporter. NF- κ B signaling in was measured after 18 h treatment with TNF α (10 ng/ml) and/or IKK β inhibitor (2.5 μ M). Data are arbitrary luciferase units normalized to XTT and are represented as mean±S.E.M.; * P <0.05 based on t -test. ( b ) mRNA expression of Caspase8 and NF- κ B target genes cFLIP, CLDN1, CXCL1, CXCL2 and IL-8 was measured by quantitative RT-PCR in Ovcar3 cells, expressing either control or Caspase8 shRNA. Expression was normalized to that of GAPDH, and expressed as mean±S.E.M. of triplicate experiments. * P <0.05 based on t -test.

Article Snippet: Ovcar3 cells were transduced with a lentiviral vector containing an NF- κ B transcriptional regulatory element, using the Cignal Lenti Reporter System (CLS-013L, Qiagen, Valencia, CA, USA).

Techniques: Inhibition, Activation Assay, Expressing, Control, shRNA, Transduction, Luciferase, Quantitative RT-PCR

Necroptosis, but not apoptosis, is prominent in Caspase8-depleted cells. ( a ) Cells expressing either control or Caspase8 shRNA were exposed to Caspase8 inhibitor ZIETD (25 μ M), staurosporine (1 μ M), TNF α (10 ng/ml) and/or IKK β inhibitor (2.5 μ M), to induce caspase activity. Results are expressed as average luciferase units ±S.E.M., n =16. * P <0.05 based on t -test. ( b ) CASPASE 3 and 7 activity was measured in Ovcar3 cells exposed to similar conditions as in a . ( c ) Control shRNA-transduced Ovcar3 cells were exposed to IKK β inhibitor with or without TNF α stimulation, in the presence of apoptosis inhibitor ZIETD, or NEC1, a known inhibitor of necroptosis. Cells were treated for 18 h with TNF α (10 ng/ml), IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM), and/or ZIETD (25 μ M) or NEC1 (25 μ M) as indicated. Viability was assessed by XTT assay. Results are expressed as average±S.E.M., n =8. ( d ) Caspase8-depleted cells were treated as in b .

Journal: Cell Death Discovery

Article Title: A dual role for Caspase8 and NF- κ B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival

doi: 10.1038/cddiscovery.2015.53

Figure Lengend Snippet: Necroptosis, but not apoptosis, is prominent in Caspase8-depleted cells. ( a ) Cells expressing either control or Caspase8 shRNA were exposed to Caspase8 inhibitor ZIETD (25 μ M), staurosporine (1 μ M), TNF α (10 ng/ml) and/or IKK β inhibitor (2.5 μ M), to induce caspase activity. Results are expressed as average luciferase units ±S.E.M., n =16. * P <0.05 based on t -test. ( b ) CASPASE 3 and 7 activity was measured in Ovcar3 cells exposed to similar conditions as in a . ( c ) Control shRNA-transduced Ovcar3 cells were exposed to IKK β inhibitor with or without TNF α stimulation, in the presence of apoptosis inhibitor ZIETD, or NEC1, a known inhibitor of necroptosis. Cells were treated for 18 h with TNF α (10 ng/ml), IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM), and/or ZIETD (25 μ M) or NEC1 (25 μ M) as indicated. Viability was assessed by XTT assay. Results are expressed as average±S.E.M., n =8. ( d ) Caspase8-depleted cells were treated as in b .

Article Snippet: Ovcar3 cells were transduced with a lentiviral vector containing an NF- κ B transcriptional regulatory element, using the Cignal Lenti Reporter System (CLS-013L, Qiagen, Valencia, CA, USA).

Techniques: Expressing, Control, shRNA, Activity Assay, Luciferase, XTT Assay

Caspase8-depleted ovarian cancer cells show evidence of cell death by necroptosis. ( a ) Western analysis was performed on cell lysates obtained from Ovcar3 and Caov3 cells expressing control or Caspase8 shRNA #2, after treatment with IKK β inhibitor (2.5 μ M) and/or TNF α (10 ng/ml) for 18 h. Protein levels of Caspase8, RIPK1 (uncleaved, 78 kDa), MLKL and cleaved PARP are shown. GAPDH was used as loading control ( b ) Western analysis was performed on cell lysates obtained from Ovcar3 cells expressing control or Caspase8 shRNA #2, after treatment with IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM) and/or TNF α (10 ng/ml) for 18 h. Protein levels of Caspase8, RIPK1 (uncleaved, 78 kDa), MLKL, cIAP1 and cleaved PARP are shown (upper). β -Tubulin was used as loading control. ( c ) Ovcar3 cells expressing either control or Caspase8 shRNA #2 were transiently transduced with control or RIPK1 siRNA. ( d ) Ovcar3 cells described in c were exposed to IKK β inhibitor with or without TNF α stimulation, in the presence of apoptosis inhibitor (ZIETD) or necroptosis inhibitor (NEC1). Cells were treated for 18 h with TNF α (10 ng/ml), IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM) and/or ZIETD (25 μ M) or NEC1 (25 μ M) as indicated. Viability was assessed by XTT assay. Results are expressed as average±S.E.M., n =8, * P <0.01 based on t -test, and shown as percent change from no treatment control.

Journal: Cell Death Discovery

Article Title: A dual role for Caspase8 and NF- κ B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival

doi: 10.1038/cddiscovery.2015.53

Figure Lengend Snippet: Caspase8-depleted ovarian cancer cells show evidence of cell death by necroptosis. ( a ) Western analysis was performed on cell lysates obtained from Ovcar3 and Caov3 cells expressing control or Caspase8 shRNA #2, after treatment with IKK β inhibitor (2.5 μ M) and/or TNF α (10 ng/ml) for 18 h. Protein levels of Caspase8, RIPK1 (uncleaved, 78 kDa), MLKL and cleaved PARP are shown. GAPDH was used as loading control ( b ) Western analysis was performed on cell lysates obtained from Ovcar3 cells expressing control or Caspase8 shRNA #2, after treatment with IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM) and/or TNF α (10 ng/ml) for 18 h. Protein levels of Caspase8, RIPK1 (uncleaved, 78 kDa), MLKL, cIAP1 and cleaved PARP are shown (upper). β -Tubulin was used as loading control. ( c ) Ovcar3 cells expressing either control or Caspase8 shRNA #2 were transiently transduced with control or RIPK1 siRNA. ( d ) Ovcar3 cells described in c were exposed to IKK β inhibitor with or without TNF α stimulation, in the presence of apoptosis inhibitor (ZIETD) or necroptosis inhibitor (NEC1). Cells were treated for 18 h with TNF α (10 ng/ml), IKK β inhibitor (2.5 μ M), SMAC-mimetic (birinapant 200 nM) and/or ZIETD (25 μ M) or NEC1 (25 μ M) as indicated. Viability was assessed by XTT assay. Results are expressed as average±S.E.M., n =8, * P <0.01 based on t -test, and shown as percent change from no treatment control.

Article Snippet: Ovcar3 cells were transduced with a lentiviral vector containing an NF- κ B transcriptional regulatory element, using the Cignal Lenti Reporter System (CLS-013L, Qiagen, Valencia, CA, USA).

Techniques: Western Blot, Expressing, Control, shRNA, Transduction, XTT Assay

Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, OVCAR3, SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.

Journal: British Journal of Cancer

Article Title: BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers

doi: 10.1038/sj.bjc.6605161

Figure Lengend Snippet: Assessing BubR1 and Aurora A levels and localisation in ovarian cancer cells. ( A ) Western blot analysis of ovarian cancer cell lines, OVCAR3, SK-OV-3, and SNU119, using anti-BubR1 and Aurora A antibodies. ( B ) Immunofluorescence analysis of ovarian cancer cell lines (OVCAR3, SK-OV-3, and SNU119). Cells grown on cover slips were fixed and immunostained with anti-BubR1 (red) and anti-Aurora A (green) antibodies. DAPI (blue) staining reveals chromosomes. ( C ) Cytogenic analysis of ovarian cancer cell lines. Ten different metaphase chromosome spreads were analysed for their chromosome number. All three ovarian cancer cell lines are aneuploid. Diploid cells should have 46 chromosomes. ( D ) Representative metaphase chromosome spreads showing chromosome number aberrations in the three cell lines analysed. In OVCAR3, chromosome fusions, another important measure of CIN, were observed in OVCAR3 and are marked as arrows. Scale bars are marked. (E) Immunofluorescence analysis of three primary ovarian cancer cells (Ov_ca_01, Ov_ca_02, and Ov_ca_03). Images were taken and processed on a DeltaVision RT (Applied Precision) with × 1000 magnification. White scale bars 15 μ m.

Article Snippet: Human ovarian cancer cell lines, OVCAR3, SK-OV-3, and SNU119, were obtained from the Korean Cell Line Bank and grown in monolayer cultures in RPMI 1640 supplemented with fetal bovine serum (10% v/v).

Techniques: Western Blot, Immunofluorescence, Staining